The Neuroendocrine Tumor Research Foundation directs your individual donations to breakthrough scientific research. Since 2005, we have funded $37.6 million in research projects. The Neuroendocrine Research Foundation is a 501(c)(3) organization, so all donations are fully tax-deductible to the extent allowed by law. We are grateful to you for your generosity.
The Neuroendocrine Tumor Research Foundation directs your individual donations to breakthrough scientific research. Since 2005, we have funded $37.6 million in research projects. The Neuroendocrine Research Foundation is a 501(c)(3) organization, so all donations are fully tax-deductible to the extent allowed by law. We are grateful to you for your generosity.
A small town in Maine finds its zebra stripes after two first responders and a town official succumbed to NETs since 2017. See how they are raising awareness and money for research.
Dr. Elizabeth Zide vs. Neuroendocrine Cancer Members “Nothing But NET” marathon relay team. (left to right) Elizabeth Zide, Alaina Kronenberg, and Cassi Cohen. Her lifestyle
A 29-year-old with NET cancer activates a community to raise money for NET research and brings down the house with a remarkable music festival.
Neuroendocrine Tumor Research Foundation celebrates the halfway point of Spark Hope campaign. $5.3 million raised to date.
NETRF’s Aretha Franklin Fund for Neuroendocrine Cancer Research established with a gift from Women’s Informal Network, Detroit.
Aretha Franklin was a trailblazer. She broke barriers as the first woman welcomed into the Rock and Roll Hall of Fame and as the indisputable
Coping with the uncertainty of a cancer diagnosis means finding ways to take your mind off cancer, to do what you enjoy most, finding meaning and purpose.
From a place of discouragement after being diagnosed with a NET in June 2018, Susan Garrett of Roxboro, NC, saw a news story on WRAL
Increasing Precision in Cancer Cell Death to Prevent Metastasis In housework and lawn work, it is important to have the right tool for the job.
Mark A. Lewis, MD, Director of Gastrointestinal Oncology, Intermountain Healthcare, Utah, has joined the Board of Directors for the Neuroendocrine Tumor Research Foundation. Dr. Lewis,
